Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Case Studies

Sygnature has a strong track record of delivering clinical candidates for client projects; so we are always delighted when progress into clinical development moves the compounds generated in these collaborations closer to treating the patients who need them.

When that happens our clients are often happy to disclose some of the details of the innovative putative medicines that are being assessed in clinical trials.

Below you will find examples of projects successfully completed at Sygnature. These snapshots illustrate the Sygnature values in action; delivering hits, leads and candidate drugs.

Clear search

PAINS (Pan-Assay INterference compounds)

READ CASE STUDY

Corcept Therapeutics: Integrated Drug Discovery Collaboration

READ CASE STUDY

CellCentric Lead Optimisation Campaign

READ CASE STUDY

Fragment-based hit discovery for the epigenetic target, BRD3

READ CASE STUDY

Sygnature IncuCyte ZOOM (Essen)

READ CASE STUDY

Hit Identification to 3 Compounds in the Clinic and 6…

READ CASE STUDY

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.